September 30, 2016 7:02am

 

… Too much, too fast, too far - it’s time to bite or nibble even for a Friday

Any rebound will allow the savaged to show their resilience

 

I answer one question; in which company should investors put, keep and commit their money!

 

Where is “our” universe going today?  Astute investors subscribe, you should too! 

 

I say what others won't, so you can do what others can't!

Read on, I make investors’ money!

 

 

How does the old saying go? It's easier to ask for forgiveness than ask for permission. Maybe it's the other way around. Whatever the case, to the extent I need to, I'm NOT going to ask for forgiveness for what I say – someone NEEDS to speak up and out!

 

 

Indexes and ETFs: The IWM, XLV, IBB and XBI are NOT indicating – fearful of the day ahead?

BUY: ADRO, AST, BLCM, BLUE, CLLS, JUNO, KITE, MESO, ONCE and VSTM

SELL: AGTC and CLBS

Dow futures are DOWN -0.19% and NASDAQ futures are DOWN -0.26%

 

 

U.S. stock-index futures edged lower  on Friday, as Deutsche Bank concerns pressured global banking stocks and U.S. investors awaited a major inflation indicator.                      

European stocks came off their session lows in morning trade but concerns over the systemic risk posed by German banks continued to weigh on investor sentiment.

Asia markets stumbled, the final trading day of the quarter, after concerns over Deutsche Bank undermined investor sentiment.

Data docket: August personal spending and income figures are due, along with the core PCE (personal consumption expenditures) prices. Other data due on Friday include the Chicago PMI survey for September and the final Michigan Sentiment for September at 10 a.m. ET.

 

 

The stem, cell, gene and regenerative therapy (SCG&RT) sector closed NEGATIVE on Thursday and Wednesday, POSITIVE on Tuesday, NEGATIVE on Monday and POSITIVE last Friday.

The SCG&RT sector’s record after the last 5 days (of 43 covered companies):

  • Thursday closed NEGATIVE with 35 decliners, 7 advancers and 1 flat;
  • Wednesday closed NEGATIVE with 27 decliners, 13 advancers and 3 flats;
  • Tuesday closed POSITIVE with 15 decliners, 27 advancers and 1 flat;
  • Monday closed NEGATIVE with 33 decliners, 9 advancers and 1 flat;
  • Last Friday closed POSITIVE with 20 decliners, 22 advancers and 1 flat;

 

 

Remembering Thursday’s closing post, “Consequences of volume, pricing and volatility aren’t an accident of sentiment but, the alignment of risk. It all comes down to exposure that arouses discontentment”

  • There are always changes in expectations, followed by volatility.

There is always uncertainty in the sector; whether it's oversold or overbought … it will go one way or the other. It just makes investors de-risk and traders jump the line - if there's a big move down – it’s usually time to act in response – that’s called BUY.

  • Fear on in the market has jumped!

The commonly used gauge of market concerns, the CBOE Volatility Index VIX, +2.21% rose about 15% at 14.28 on Thursday. At its peak on the day, the indicator was on track for its largest daily rise since Sept. 9, according to FactSet data, before pulling back somewhat later in the session <MarketWatch>

  • The VIX—and products based on the index—are used by traders to track and bet on the prospect of gyrations in the S&P 500. Thursday’s moves appeared to be precipitated by elevated concerns about Deutsche Bank after a <Bloomberg News> report said a group of hedge funds decreased their exposure to the largest German bank.

Some sector “participants” will reset their resistance and support base which may allow for the pattern, I keep speaking about for a reset to emerge.

 

As September winds down; could we expect any October surprises - a FEW!

 

 

You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades? 

Watch list:

  • The iShares Nasdaq Biotechnology (IBB) closed Thursday down -3.12% and is NOT indicating in Friday’s pre-market;
  • The SPDR S&P Biotech ETF (XBI) closed Thursday down -3.36% and is NOT indicating in Friday pre-market;
  • The Health Care Select Sector SPDR ETF (XLV) closed down -1.76% Thursday and is NOT indicating in Friday’s pre-market;
  • The iShares Russell 2000 (IWM) closed down -1.46% on Thursday and is NOT indicating in Friday’s pre-market.

 

 

Companies in my headlights:

Oversold:

  • Aduro Biotech (ADRO) ;
  • Asterias Biotherapeutics (NYSEMKT: AST);
  • Bellicum Pharma (BLCM);
  • Bluebird bio (BLUE);
  • Cellectis SA (CLLS);
  • Juno Therapeutics (JUNO);
  • Kite Pharma (KITE);
  • Mesoblast (MESO);
  • Spark Therapeutics (ONCE);

 

Overbought:

  • Applied Genetic Technologies (AGTC)

 

 

 

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.